Evidence map›Paper›PMID 39246263›Full record

ArticleCancer medicine2024

Global, regional, and national burdens of leukemia from 1990 to 2019: A systematic analysis of the global burden of disease in 2019 based on the APC model.

Xiang Qu, Anjie Zheng, Jie Yang, Jinru Zhang, Hongmei Qiao, Fan Jiang, Jie Zhao, Chunping Wang, Peng Ning

Abstract read
In one paragraph

Article in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiang QuXi'an Daxing Hospital, Xi'an, China.ORCID 0000-0002-1471-1319
Anjie ZhengDepartment of Oncology, Baoji Gaoxin Hospital, Baoji, China.
Jie YangDepartment of Oncology, Baoji Gaoxin Hospital, Baoji, China.
Jinru ZhangDepartment of Oncology, Baoji Gaoxin Hospital, Baoji, China.
Hongmei QiaoDepartment of Oncology, Baoji Gaoxin Hospital, Baoji, China.
Fan JiangDepartment of Oncology, Baoji Gaoxin Hospital, Baoji, China.
Jie ZhaoDepartment of Oncology, Baoji Gaoxin Hospital, Baoji, China.
Chunping WangSchool of Public Health, Shandong Second Medical University, Weifang, China.
Peng NingDepartment of Oncology, Baoji Gaoxin Hospital, Baoji, China.

Funding

Scientific Research Project of the Chinese Academy of Medical Sciences IBMS-2018-KJHT-08271810828
6 · The paper itself

Abstract

backgroundLeukemia is the tenth most common cause of cancer death worldwide and one of the most important causes of disability. To understand the current status and changing trends of the disease burden of leukemia at the global, regional, and national levels, and to provide a scientific basis for the development of leukemia prevention and treatment strategies.

methodsBased on open data from the Global Burden of Disease Study 2019 (GBD 2019), R software was used to calculate estimated annual percentage changes to estimate trends in the age-standardized incidence (ASIR) and the age-standardized disability-adjusted life years (DALY) rate due to leukemia and its major subtypes from 1990 to 2019.

resultsIn 2019, globally, the number of incidences and DALYs of leukemia were 643.6 × 10

conclusionsFrom 1990 to 2019, the disease burden of leukemia showed a decreasing trend, but it is worth noting that its overall severity is still very high. The disease burden of leukemia varies greatly from region to region, and exclusive strategies for the prevention and treatment of leukemia should be developed according to the economic and cultural development of each region.

Indexed as

Disability-Adjusted Life YearsGlobal Burden of DiseaseLeukemiaAdolescentAdultAgedFemaleGlobal HealthHumansIncidenceMaleMiddle AgedYoung Adultage‐period‐cohort modelburden of diseasedisability‐adjusted life yearsestimated annual percentage changeleukemia

Identifiers

PMID39246263
PMCPMC11381916

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.